310 related articles for article (PubMed ID: 25271871)
1. A multisite, naturalistic, observational study of transcranial magnetic stimulation for patients with pharmacoresistant major depressive disorder: durability of benefit over a 1-year follow-up period.
Dunner DL; Aaronson ST; Sackeim HA; Janicak PG; Carpenter LL; Boyadjis T; Brock DG; Bonneh-Barkay D; Cook IA; Lanocha K; Solvason HB; Demitrack MA
J Clin Psychiatry; 2014 Dec; 75(12):1394-401. PubMed ID: 25271871
[TBL] [Abstract][Full Text] [Related]
2. Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice.
Carpenter LL; Janicak PG; Aaronson ST; Boyadjis T; Brock DG; Cook IA; Dunner DL; Lanocha K; Solvason HB; Demitrack MA
Depress Anxiety; 2012 Jul; 29(7):587-96. PubMed ID: 22689344
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of transcranial magnetic stimulation in clinical practice post-FDA approval in the United States: results observed with the first 100 consecutive cases of depression at an academic medical center.
Connolly KR; Helmer A; Cristancho MA; Cristancho P; O'Reardon JP
J Clin Psychiatry; 2012 Apr; 73(4):e567-73. PubMed ID: 22579164
[TBL] [Abstract][Full Text] [Related]
4. Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study.
Janicak PG; Nahas Z; Lisanby SH; Solvason HB; Sampson SM; McDonald WM; Marangell LB; Rosenquist P; McCall WV; Kimball J; O'Reardon JP; Loo C; Husain MH; Krystal A; Gilmer W; Dowd SM; Demitrack MA; Schatzberg AF
Brain Stimul; 2010 Oct; 3(4):187-99. PubMed ID: 20965447
[TBL] [Abstract][Full Text] [Related]
5. Improvement in quality of life with left prefrontal transcranial magnetic stimulation in patients with pharmacoresistant major depression: acute and six month outcomes.
Solvason HB; Husain M; Fitzgerald PB; Rosenquist P; McCall WV; Kimball J; Gilmer W; Demitrack MA; Lisanby SH
Brain Stimul; 2014; 7(2):219-25. PubMed ID: 24332384
[TBL] [Abstract][Full Text] [Related]
6. Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of quality of life outcome measures in clinical practice.
Janicak PG; Dunner DL; Aaronson ST; Carpenter LL; Boyadjis TA; Brock DG; Cook IA; Lanocha K; Solvason HB; Bonneh-Barkay D; Demitrack MA
CNS Spectr; 2013 Dec; 18(6):322-32. PubMed ID: 23895940
[TBL] [Abstract][Full Text] [Related]
7. Can Medication Free, Treatment-Resistant, Depressed Patients Who Initially Respond to TMS Be Maintained Off Medications? A Prospective, 12-Month Multisite Randomized Pilot Study.
Philip NS; Dunner DL; Dowd SM; Aaronson ST; Brock DG; Carpenter LL; Demitrack MA; Hovav S; Janicak PG; George MS
Brain Stimul; 2016; 9(2):251-7. PubMed ID: 26708778
[TBL] [Abstract][Full Text] [Related]
8. H-coil repetitive transcranial magnetic stimulation for treatment resistant major depressive disorder: An 18-week continuation safety and feasibility study.
Harel EV; Rabany L; Deutsch L; Bloch Y; Zangen A; Levkovitz Y
World J Biol Psychiatry; 2014 May; 15(4):298-306. PubMed ID: 22313023
[TBL] [Abstract][Full Text] [Related]
9. Long-term efficacy of repeated daily prefrontal transcranial magnetic stimulation (TMS) in treatment-resistant depression.
Mantovani A; Pavlicova M; Avery D; Nahas Z; McDonald WM; Wajdik CD; Holtzheimer PE; George MS; Sackeim HA; Lisanby SH
Depress Anxiety; 2012 Oct; 29(10):883-90. PubMed ID: 22689290
[TBL] [Abstract][Full Text] [Related]
10. [Health-related quality of life assessment in depression after low-frequency transcranial magnetic stimulation].
Dumas R; Boyer L; Richieri R; Guedj E; Auquier P; Lançon C
Encephale; 2014 Feb; 40(1):74-80. PubMed ID: 24091070
[TBL] [Abstract][Full Text] [Related]
11. Left dorsolateral prefrontal transcranial magnetic stimulation (TMS): sleep factor changes during treatment in patients with pharmacoresistant major depressive disorder.
Rosenquist PB; Krystal A; Heart KL; Demitrack MA; McCall WV
Psychiatry Res; 2013 Jan; 205(1-2):67-73. PubMed ID: 23021320
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness and safety of vagus nerve stimulation for severe treatment-resistant major depression in clinical practice after FDA approval: outcomes at 1 year.
Cristancho P; Cristancho MA; Baltuch GH; Thase ME; O'Reardon JP
J Clin Psychiatry; 2011 Oct; 72(10):1376-82. PubMed ID: 21295002
[TBL] [Abstract][Full Text] [Related]
13. Brief dynamic therapy combined with pharmacotherapy in the treatment of major depressive disorder: long-term results.
Maina G; Rosso G; Bogetto F
J Affect Disord; 2009 Apr; 114(1-3):200-7. PubMed ID: 18728001
[TBL] [Abstract][Full Text] [Related]
14. Transcranial magnetic stimulation in the acute treatment of major depressive disorder: clinical response in an open-label extension trial.
Avery DH; Isenberg KE; Sampson SM; Janicak PG; Lisanby SH; Maixner DF; Loo C; Thase ME; Demitrack MA; George MS
J Clin Psychiatry; 2008 Mar; 69(3):441-51. PubMed ID: 18294022
[TBL] [Abstract][Full Text] [Related]
15. Behavioral activation therapy during transcranial magnetic stimulation for major depressive disorder.
Russo GB; Tirrell E; Busch A; Carpenter LL
J Affect Disord; 2018 Aug; 236():101-104. PubMed ID: 29723763
[TBL] [Abstract][Full Text] [Related]
16. The efficacy profile of vilazodone, a novel antidepressant for the treatment of major depressive disorder.
Reed CR; Kajdasz DK; Whalen H; Athanasiou MC; Gallipoli S; Thase ME
Curr Med Res Opin; 2012 Jan; 28(1):27-39. PubMed ID: 22106941
[TBL] [Abstract][Full Text] [Related]
17. A clinical repetitive transcranial magnetic stimulation service in Australia: 6 years on.
Galletly CA; Clarke P; Carnell BL; Gill S
Aust N Z J Psychiatry; 2015 Nov; 49(11):1040-7. PubMed ID: 26508800
[TBL] [Abstract][Full Text] [Related]
18. Transcranial magnetic stimulation for major depressive disorder: a pragmatic approach to implementing TMS in a clinical practice.
Derstine T; Lanocha K; Wahlstrom C; Hutton TM
Ann Clin Psychiatry; 2010 Nov; 22(4 Suppl):S4-11. PubMed ID: 21180663
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of transcranial magnetic stimulation in the treatment of major depression: a health economics analysis.
Simpson KN; Welch MJ; Kozel FA; Demitrack MA; Nahas Z
Adv Ther; 2009 Mar; 26(3):346-68. PubMed ID: 19330495
[TBL] [Abstract][Full Text] [Related]
20. Effect of antidepressant medication treatment on suicidal ideation and behavior in a randomized trial: an exploratory report from the Combining Medications to Enhance Depression Outcomes Study.
Zisook S; Lesser IM; Lebowitz B; Rush AJ; Kallenberg G; Wisniewski SR; Nierenberg AA; Fava M; Luther JF; Morris DW; Trivedi MH
J Clin Psychiatry; 2011 Oct; 72(10):1322-32. PubMed ID: 22075098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
